SUN-C5174 (S)-ISOMER

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H29FN4O2
Molecular Weight	400.4897
Optical Activity	( - )
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C=CC2=C1[C@@H](O)CCN(CCCN3CCN(CC3)C4=CC=C(F)C=C4)C2=O

InChI

InChIKey=KBZUFSZQLVRGPR-FQEVSTJZSA-N

InChI=1S/C22H29FN4O2/c1-24-11-7-19-21(24)20(28)8-12-27(22(19)29)10-2-9-25-13-15-26(16-14-25)18-5-3-17(23)4-6-18/h3-7,11,20,28H,2,8-10,12-16H2,1H3/t20-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C22H29FN4O2
Molecular Weight	400.4897
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 11:29:58 GMT 2023` Edited by `admin` on `Sat Dec 16 11:29:58 GMT 2023`
Record UNII	QK5D76D47T
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SUN-C5174 (S)-ISOMER

Common Name

English

SUN-C5174

Code

English

PYRROLO(3,2-C)AZEPIN-4(1H)-ONE, 5-(3-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)PROPYL)-5,6,7,8-TETRAHYDRO-8-HYDROXY-1-METHYL-, (S)-

Systematic Name

English

(8S)-5-(3-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)PROPYL)-8-HYDROXY-1-METHYL-7,8-DIHYDRO-6H-PYRROLO(3,2-C)AZEPIN-4-ONE-

Systematic Name

English

Code System Code Type Description

PUBCHEM

9801124

Created by admin on Sat Dec 16 11:29:58 GMT 2023 , Edited by admin on Sat Dec 16 11:29:58 GMT 2023

PRIMARY

MANUFACTURER PRODUCT INFORMATION

SUN-C5174((S)-ISOMER)

Created by admin on Sat Dec 16 11:29:58 GMT 2023 , Edited by admin on Sat Dec 16 11:29:58 GMT 2023

PRIMARY

FDA UNII

QK5D76D47T

Created by admin on Sat Dec 16 11:29:58 GMT 2023 , Edited by admin on Sat Dec 16 11:29:58 GMT 2023

PRIMARY

CAS

191592-36-6

Created by admin on Sat Dec 16 11:29:58 GMT 2023 , Edited by admin on Sat Dec 16 11:29:58 GMT 2023

PRIMARY

Related Record Type Details


					LEV29G9Q9T

5-HT2 ANTAGONIST 1

RACEMATE -> ENANTIOMER

Comments:

Mechanism of Action Alpha 1 adrenergic receptor agonists Serotonin receptor antagonists, 18 Jun 2002 Discontinued - Phase-II for Arterial occlusive disorders in Japan (PO)

Amount: